Curis
CRIS
#10201
Rank
S$22.61 M
Marketcap
S$1.75
Share price
0.00%
Change (1 day)
-66.91%
Change (1 year)

Curis (CRIS) - Total debt

Total debt on the balance sheet as of September 2025 : S$2.55 Million

According to Curis's latest financial reports the company's total debt is S$2.55 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Curis - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$4.01 M8.81%
2023-12-31S$3.69 M-30.16%
2022-12-31S$5.28 M-22.46%
2021-12-31S$6.81 M-32.78%
2020-12-31S$10.13 M4429.25%
2019-12-31S$0.22 M-99.54%
2018-12-31S$48.47 M-12.78%
2017-12-31S$55.57 M93.37%
2016-12-31S$28.74 M-15.91%
2015-12-31S$34.18 M-8.59%
2014-12-31S$37.39 M-3.41%
2013-12-31S$38.71 M6.09%
2012-12-31S$36.49 M
2008-12-31N/A-100%
2007-12-31S$0.58 M-80.86%
2006-12-31S$3.03 M-68.74%
2005-12-31S$9.71 M-13.12%
2004-12-31S$11.17 M16.3%
2003-12-31S$9.61 M-55.39%
2002-12-31S$21.54 M10.11%
2001-12-31S$19.56 M84.23%
2000-12-31S$10.61 M370.07%
1999-12-31S$2.25 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Exelixis
EXEL
S$0.22 B 8,866.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.85 B 33,594.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S$37.37 M 1,365.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$3.39 M 33.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$78.85 B 3,091,769.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$66.14 B 2,593,446.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S$12.91 M 406.30%๐Ÿ‡บ๐Ÿ‡ธ USA